Biotech Group Acquisition Corporation (BGAC)
Biotech Group Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Company Description
Biotech Group Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of directors to focus on biotechnology companies with the potential to capitalize on the growing biotechnology sector in North America and the Asia-Pacific region (excluding China, Hong Kong and Macau).
Biotech Group Acquisition Corporation
| Country | United States |
| Founded | 2022 |
| Industry | Blank Check / SPAC |
| CEO | Yiru (Melody) Shi |
Contact Details
Address:
2400 Barranca Pkwy, Suite 300 Irvine, CA 92606 United States | |
| Phone | (949) 468-7078 |
Stock Details
| Ticker Symbol | BGAC |
| Exchange | NASDAQ |
| Reporting Currency | US Dollars |
| IPO Price | $10.00 |
| CIK Code | 1916902 |
Key Executives
| Name | Position |
|---|---|
| Yiru (Melody) Shi | Chief Executive Officer and Chairwoman |
| Manu Ohri | Chief Financial Officer and Director Nominee |
| Jingmin (Helen) Rogers | Director Nominee |
| John Brugmann | Director Nominee |
| Yi Wung | Director Nominee |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 25, 2022 | S-1/A | General form for registration of securities under the Securities Act of 1933 |
| Apr 15, 2022 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Mar 18, 2022 | DRS | Draft Registration Statement |